A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 Diabetes

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 11, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

April 30, 2027

Conditions

Type 2 Diabetes

Interventions

DRUG

SHR-3167 Injection

SHR-3167 injection.

DRUG

Insulin Degludec Injection

Insulin Degludec injection.

Trial Locations (1)

RECRUITING

West China Hospital of Sichuan University, Chengdu

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY